{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["2019"],"submitter":["Pires BRB"],"funding":["Fundação Araucária","Institutos Nacionais de Ciência e Tecnologia para o Controle do Câncer","Conselho Nacional de Desenvolvimento Científico e Tecnológico","Programa Pesquisa Para o SUS","Ministério da Saúde","Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro"],"pubmed_abstract":["Breast cancer is the leading cause of cancer-associated death among women worldwide. Its high mortality rate is related to resistance towards chemotherapies, which is one of the major challenges of breast cancer research. In this study, we used label-free mass spectrometry- (MS-) based proteomics to investigate the differences between circulating proteins in the plasma of patients with chemoresponsive and chemoresistant luminal A breast cancer. MS analysis revealed 205 differentially expressed proteins. Furthermore, we used in silico tools to build protein-protein interaction networks. Most of the upregulated proteins in the chemoresistant group were closely related and tightly linked. The predominant networks were related to oxidative stress, the inflammatory response, and the complement "],"journal":["Oxidative medicine and cellular longevity"],"pagination":["5357649"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC6702830"],"repository":["biostudies-literature"],"pubmed_title":["Label-Free Proteomics Revealed Oxidative Stress and Inflammation as Factors That Enhance Chemoresistance in Luminal Breast Cancer."],"pmcid":["PMC6702830"],"pubmed_authors":["Panis C","Pizzatti L","Alves VD","Cecchini R","Binato R","Herrera ACSA","Pires BRB","Abdelhay E"],"additional_accession":[]},"is_claimable":false,"name":"Label-Free Proteomics Revealed Oxidative Stress and Inflammation as Factors That Enhance Chemoresistance in Luminal Breast Cancer.","description":"Breast cancer is the leading cause of cancer-associated death among women worldwide. Its high mortality rate is related to resistance towards chemotherapies, which is one of the major challenges of breast cancer research. In this study, we used label-free mass spectrometry- (MS-) based proteomics to investigate the differences between circulating proteins in the plasma of patients with chemoresponsive and chemoresistant luminal A breast cancer. MS analysis revealed 205 differentially expressed proteins. Furthermore, we used in silico tools to build protein-protein interaction networks. Most of the upregulated proteins in the chemoresistant group were closely related and tightly linked. The predominant networks were related to oxidative stress, the inflammatory response, and the complement ","dates":{"release":"2019-01-01T00:00:00Z","publication":"2019","modification":"2026-06-19T03:18:12.53Z","creation":"2019-09-12T07:02:19Z"},"accession":"S-EPMC6702830","cross_references":{"pubmed":["31485295"],"doi":["10.1155/2019/5357649"]}}